Results 171 to 180 of about 50,558 (217)

Ritonavir

, 2000
openaire   +1 more source

Clarifications in JAMA Clinical Guidelines Synopsis.

JAMA
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ritonavir

Drugs, 1996
Ritonavir is a protease inhibitor with an HIV-1 resistance profile similar to that of indinavir, but different from that of saquinavir. Ritonavir has good oral bioavailability, and may increase the bioavailability of other protease inhibitors including saquinavir, nelfinavir, indinavir and VX-478.
A P, Lea, D, Faulds
  +6 more sources

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Intensive Care Medicine, 2021
Purpose: To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19).
Patrick Lawler, Charlotte Bradbury
exaly   +2 more sources

The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?

International Journal of Molecular Sciences, 2022
Ritonavir is the most potent cytochrome P450 (CYP) 3A4 inhibitor in clinical use and is often applied as a booster for drugs with low oral bioavailability due to CYP3A4-mediated biotransformation, as in the treatment of HIV (e.g., lopinavir/ritonavir ...
Alfred H Schinkel, Jos Beijnen, Nancy H C Loos   +2 more
exaly   +2 more sources

Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma

Molecular Carcinogenesis, 2019
The main focus of this study is exploring the effect and mechanism of two HIV-protease inhibitors: Ritonavir and Ritonavir-nitric oxide (Ritonavir-NO) on in vitro growth of melanoma cell lines.
Yousef Al-Abed, Katia Mangano, Sanja Mijatović   +2 more
exaly   +2 more sources

The fate of ritonavir in the presence of darunavir

International Journal of Pharmaceutics, 2014
This study was the first investigation into the potential of a fixed dose combination of ritonavir and darunavir in the form of dispersible powders prepared by spray drying.
G van den Mooter
exaly   +2 more sources

Lopinavir/Ritonavir

Journal of the Association of Nurses in AIDS Care, 2001
Treatment Review is intended to inform and update nurses about treatments relevant to HIV/AIDS. Product information presented in this column does not imply endorsement by the Association of Nurses in AIDS Care.
openaire   +2 more sources